NCT04402515View on ClinicalTrials.gov

Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 28, 2021

Primary Completion Date

January 15, 2022

Study Completion Date

January 31, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

TIO/OLO

Tiotropium/Olodaterol

DRUG

ICS

inhaled cortocosteroids

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY